SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-24-000176
Filing Date
2024-02-06
Accepted
2024-02-06 16:15:29
Documents
17
Period of Report
2024-02-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 USANA HEALTH SCIENCES, INC. 8-K a53892955.htm   iXBRL 8-K 31018
2 EXHIBIT 99.1 a53892955ex99_1.htm EX-99.1 228306
3 EXHIBIT 99.2 a53892955ex99_2.htm EX-99.2 95601
7 logo.jpg GRAPHIC 8322
  Complete submission text file 0001157523-24-000176.txt   532631

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA usna-20240206.xsd EX-101.SCH 3857
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE usna-20240206_lab.xml EX-101.LAB 22547
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE usna-20240206_pre.xml EX-101.PRE 16039
18 EXTRACTED XBRL INSTANCE DOCUMENT a53892955_htm.xml XML 4080
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

IRS No.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35024 | Film No.: 24600462
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)